1. Home
  2. OPK vs ATUS Comparison

OPK vs ATUS Comparison

Compare OPK & ATUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
    SELLHOLDBUYas of 19 hours ago
  • ATUS
    SELLHOLDBUYas of 19 hours ago
  • Stock Information
  • Founded
  • OPK 2007
  • ATUS 2015
  • Country
  • OPK United States
  • ATUS United States
  • Employees
  • OPK N/A
  • ATUS N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • ATUS Cable & Other Pay Television Services
  • Sector
  • OPK Health Care
  • ATUS Telecommunications
  • Exchange
  • OPK Nasdaq
  • ATUS Nasdaq
  • Market Cap
  • OPK 1.3B
  • ATUS 1.2B
  • IPO Year
  • OPK 1995
  • ATUS 2017
  • Fundamental
  • Price
  • OPK $1.66
  • ATUS $2.68
  • Analyst Decision
  • OPK Strong Buy
  • ATUS Hold
  • Analyst Count
  • OPK 3
  • ATUS 10
  • Target Price
  • OPK $2.75
  • ATUS $2.22
  • AVG Volume (30 Days)
  • OPK 6.4M
  • ATUS 2.4M
  • Earning Date
  • OPK 05-06-2025
  • ATUS 05-01-2025
  • Dividend Yield
  • OPK N/A
  • ATUS N/A
  • EPS Growth
  • OPK N/A
  • ATUS N/A
  • EPS
  • OPK N/A
  • ATUS N/A
  • Revenue
  • OPK $713,142,000.00
  • ATUS $8,954,417,000.00
  • Revenue This Year
  • OPK N/A
  • ATUS N/A
  • Revenue Next Year
  • OPK $6.25
  • ATUS N/A
  • P/E Ratio
  • OPK N/A
  • ATUS N/A
  • Revenue Growth
  • OPK N/A
  • ATUS N/A
  • 52 Week Low
  • OPK $1.15
  • ATUS $1.52
  • 52 Week High
  • OPK $2.04
  • ATUS $3.20
  • Technical
  • Relative Strength Index (RSI)
  • OPK 40.64
  • ATUS 50.15
  • Support Level
  • OPK $1.75
  • ATUS $2.53
  • Resistance Level
  • OPK $1.80
  • ATUS $2.62
  • Average True Range (ATR)
  • OPK 0.06
  • ATUS 0.11
  • MACD
  • OPK -0.02
  • ATUS 0.03
  • Stochastic Oscillator
  • OPK 6.67
  • ATUS 68.81

Stock Price Comparison Chart: OPK vs ATUS

OPK
ATUS
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250510152025303540OPK VS ATUS

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

About ATUS Altice USA Inc.

Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and business in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York and i24News, a news operation focused on the Middle East.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use